IV Iron Drug Shows Advantages in Head-to-Head Trial Renal and Urology News PHILADELPHIA—Ferumoxytol has an efficacy comparable to iron sucrose in treating iron deficiency anemia in patients with chronic kidney disease (CKD), but is associated with lower adverse event (AE) rates, according to the findings a head-to-head ... AMAG Pharmaceuticals, Inc. Announces Positive Data from the FIRST Trial, A ... |
